Increased Plasma Heme Oxygenase-1 Levels in Patients With Early-Stage Parkinson's Disease

被引:17
作者
Sun, Wenhua [1 ,2 ]
Zheng, Jinhua [1 ,2 ,3 ]
Ma, Jianjun [1 ,2 ,3 ]
Wang, Zhidong [1 ,2 ]
Shi, Xiaoxue [1 ,2 ]
Li, Mingjian [1 ,2 ,3 ]
Huang, Shen [1 ,2 ]
Hu, Shiyu [1 ,2 ,3 ]
Zhao, Zhenxiang [1 ,2 ,3 ]
Li, Dongsheng [1 ,2 ,3 ]
机构
[1] Zhengzhou Univ, Dept Neurol, Peoples Hosp, Zhengzhou, Peoples R China
[2] Henan Prov Peoples Hosp, Dept Neurol, Zhengzhou, Peoples R China
[3] Henan Univ, Dept Neurol, Peoples Hosp, Zhengzhou, Peoples R China
来源
FRONTIERS IN AGING NEUROSCIENCE | 2021年 / 13卷
关键词
biomarker; heme oxygenase-1; Parkinson’ s disease; plasma; voxel-based morphometry; OVEREXPRESSING HUMAN HO-1; HIPPOCAMPAL VOLUME; DEPRESSIVE SYMPTOMS; OXIDATIVE STRESS; OVER-EXPRESSION; IRON DEPOSITION; FEATURES; PROTEIN;
D O I
10.3389/fnagi.2021.621508
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Introduction: Heme oxygenase-1 (HO-1) is a 32 kDa stress-response protein implicated in the pathogenesis of Parkinson's disease (PD). Biliverdin is derived from heme through a reaction mediated by HO-1 and protects cells from oxidative stress. However, iron and carbon monoxide produced by the catabolism of HO-1 exert detrimental effects on patients with PD. The purpose of this study was to determine whether plasma HO-1 levels represent a biomarker of PD and to further explore the underlying mechanism of increased HO-1 levels by applying voxel-based morphometry (VBM).Methods: We measured plasma HO-1 levels using an enzyme-linked immunosorbent assay (ELISA) in 156 subjects, including 81 patients with early- and advanced-stage PD and 75 subjects without PD. The analyses were adjusted to control for confounders such as age, sex, and medication. We analyzed T1-weighted magnetic resonance imaging (MRI) data from 74 patients with PD using VBM to elucidate the association between altered brain volumes and HO-1 levels. Then, we compared performance on MMSE sub-items between PD patients with low and high levels of HO-1 using Mann-Whitney U tests.Results: Plasma HO-1 levels were significantly elevated in PD patients, predominantly those with early-stage PD, compared with controls (p < 0.05). The optimal cutoff value for patients with early PD was 2.245 ng/ml HO-1 [area under the curve (AUC) = 0.654]. Plasma HO-1 levels were unaffected by sex, age, and medications (p > 0.05). The right hippocampal volume was decreased in the subset of PD patients with high HO-1 levels (p < 0.05). A weak correlation was observed between right hippocampal volume and plasma HO-1 levels (r = -0.273, p = 0.018). There was no difference in total MMSE scores between the low- and high-HO-1 groups (p > 0.05), but the high-HO-1 group had higher language scores than the low-HO-1 group (p < 0.05).Conclusions: Plasma HO-1 levels may be a promising biomarker of early PD. Moreover, a high plasma concentration of the HO-1 protein is associated with a reduction in right hippocampal volume.
引用
收藏
页数:9
相关论文
共 41 条
  • [1] Plasma Heme Oxygenase-1 Concentration Is Elevated in Individuals with Type 2 Diabetes Mellitus
    Bao, Wei
    Song, Fangfang
    Li, Xiangyang
    Rong, Shuang
    Yang, Wei
    Zhang, Muxun
    Yao, Ping
    Hao, Liping
    Yang, Nianhong
    Hu, Frank B.
    Liu, Liegang
    [J]. PLOS ONE, 2010, 5 (08):
  • [2] Oxidative stress and Parkinson's disease
    Blesa, Javier
    Trigo-Damas, Ines
    Quiroga-Varela, Anna
    Jackson-Lewis, Vernice R.
    [J]. FRONTIERS IN NEUROANATOMY, 2015, 9
  • [3] The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology
    Chard, DT
    Parker, GJM
    Griffin, CMB
    Thompson, AJ
    Miller, DH
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2002, 15 (03) : 259 - 267
  • [4] Presymptomatic hippocampal atrophy in Alzheimer's disease - A longitudinal MRI study
    Fox, NC
    Warrington, EK
    Freeborough, PA
    Hartikainen, P
    Kennedy, AM
    Stevens, JM
    Rossor, MN
    [J]. BRAIN, 1996, 119 : 2001 - 2007
  • [5] Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale Presentation and Clinimetric Testing Results
    Goetz, Christopher G.
    Tilley, Barbara C.
    Shaftman, Stephanie R.
    Stebbins, Glenn T.
    Fahn, Stanley
    Martinez-Martin, Pablo
    Poewe, Werner
    Sampaio, Cristina
    Stern, Matthew B.
    Dodel, Richard
    Dubois, Bruno
    Holloway, Robert
    Jankovic, Joseph
    Kulisevsky, Jaime
    Lang, Anthony E.
    Lees, Andrew
    Leurgans, Sue
    LeWitt, Peter A.
    Nyenhuis, David
    Olanow, C. Warren
    Rascol, Olivier
    Schrag, Anette
    Teresi, Jeanne A.
    van Hilten, Jacobus J.
    LaPelle, Nancy
    [J]. MOVEMENT DISORDERS, 2008, 23 (15) : 2129 - 2170
  • [6] Depressive symptoms in Parkinson's disease are related to decreased left hippocampal volume: correlation with the 15-item shortened version of the Geriatric Depression Scale
    Goto, Masami
    Kamagata, Koji
    Hatano, Taku
    Hattori, Nobutaka
    Abe, Osamu
    Aoki, Shigeki
    Hori, Masaaki
    Gomi, Tsutomu
    [J]. ACTA RADIOLOGICA, 2018, 59 (03) : 341 - 345
  • [7] Testing experimental data for univariate normality
    Henderson, AR
    [J]. CLINICA CHIMICA ACTA, 2006, 366 (1-2) : 112 - 129
  • [8] ACCURACY OF CLINICAL-DIAGNOSIS OF IDIOPATHIC PARKINSONS-DISEASE - A CLINICOPATHOLOGICAL STUDY OF 100 CASES
    HUGHES, AJ
    DANIEL, SE
    KILFORD, L
    LEES, AJ
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (03) : 181 - 184
  • [9] Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
    Jack, CR
    Petersen, RC
    Xu, YC
    O'Brien, PC
    Smith, GE
    Ivnik, RJ
    Boeve, BF
    Waring, SC
    Tangalos, EG
    Kokmen, E
    [J]. NEUROLOGY, 1999, 52 (07) : 1397 - 1403
  • [10] Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia
    Kaye, JA
    Swihart, T
    Howieson, D
    Dame, A
    Moore, MM
    Karnos, T
    Camicioli, R
    Ball, M
    Oken, B
    Sexton, G
    [J]. NEUROLOGY, 1997, 48 (05) : 1297 - 1304